 | • レポートコード：QYR9ST04766 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、慢性閉塞性肺疾患の世界市場について調査・分析し、慢性閉塞性肺疾患の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（気管支拡張剤、グルココルチコイド、その他）、用途別（予防、診断、治療）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の慢性閉塞性肺疾患市場動向 ・主要企業別マーケットシェア ・慢性閉塞性肺疾患の種類別市場規模2014-2019 （気管支拡張剤、グルココルチコイド、その他） ・慢性閉塞性肺疾患の用途別市場規模2014-2019 （予防、診断、治療） ・慢性閉塞性肺疾患の北米市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の中国市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の日本国内市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の東南アジア市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患のインド市場：主要企業・種類別/用途別市場規模 ・慢性閉塞性肺疾患の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （AstraZeneca、GSK、MSD、Sunovion、Novartis、Roche Group、Pfizer、Jubilant Pharma Limited、Almirall、Horizon Pharma、Boehringer Ingelheim） ・慢性閉塞性肺疾患の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time. Eventually everyday activities, such as walking or getting dressed, become difficult .Chronic bronchitis and emphysema are older terms used for different types of COPD.Globally the market for COPD is increasing rapidly. The major factor that derives the growth of COPD is the increasing growth in smoking in adults. Furthermore increasing pollution in the environment and increasing asthma patients are increasing the growth of COPD market.
In 2018, the global Chronic Obstructive Pulmonary Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Chronic Obstructive Pulmonary Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Chronic Obstructive Pulmonary Disease development in United States, Europe and China.
The key players covered in this study
AstraZeneca
GSK
MSD
Sunovion
Novartis
Roche Group
Pfizer
Jubilant Pharma Limited
Almirall
Horizon Pharma
Boehringer Ingelheim
Market segment by Type, the product can be split into
Bronchodilators
Glucocorticoids
Other
Market segment by Application, split into
Prevention
Diagnostic
Treatment
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Chronic Obstructive Pulmonary Disease status, future forecast, growth opportunity, key market and key players.
To present the Chronic Obstructive Pulmonary Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Chronic Obstructive Pulmonary Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type (2014-2025)
1.4.2 Bronchodilators
1.4.3 Glucocorticoids
1.4.4 Other
1.5 Market by Application
1.5.1 Global Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2025)
1.5.2 Prevention
1.5.3 Diagnostic
1.5.4 Treatment
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Chronic Obstructive Pulmonary Disease Market Size
2.2 Chronic Obstructive Pulmonary Disease Growth Trends by Regions
2.2.1 Chronic Obstructive Pulmonary Disease Market Size by Regions (2014-2025)
2.2.2 Chronic Obstructive Pulmonary Disease Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Chronic Obstructive Pulmonary Disease Market Size by Manufacturers
3.1.1 Global Chronic Obstructive Pulmonary Disease Revenue by Manufacturers (2014-2019)
3.1.2 Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Chronic Obstructive Pulmonary Disease Market Concentration Ratio (CR5 and HHI)
3.2 Chronic Obstructive Pulmonary Disease Key Players Head office and Area Served
3.3 Key Players Chronic Obstructive Pulmonary Disease Product/Solution/Service
3.4 Date of Enter into Chronic Obstructive Pulmonary Disease Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019)
4.2 Global Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019)
5 United States
5.1 United States Chronic Obstructive Pulmonary Disease Market Size (2014-2019)
5.2 Chronic Obstructive Pulmonary Disease Key Players in United States
5.3 United States Chronic Obstructive Pulmonary Disease Market Size by Type
5.4 United States Chronic Obstructive Pulmonary Disease Market Size by Application
6 Europe
6.1 Europe Chronic Obstructive Pulmonary Disease Market Size (2014-2019)
6.2 Chronic Obstructive Pulmonary Disease Key Players in Europe
6.3 Europe Chronic Obstructive Pulmonary Disease Market Size by Type
6.4 Europe Chronic Obstructive Pulmonary Disease Market Size by Application
7 China
7.1 China Chronic Obstructive Pulmonary Disease Market Size (2014-2019)
7.2 Chronic Obstructive Pulmonary Disease Key Players in China
7.3 China Chronic Obstructive Pulmonary Disease Market Size by Type
7.4 China Chronic Obstructive Pulmonary Disease Market Size by Application
8 Japan
8.1 Japan Chronic Obstructive Pulmonary Disease Market Size (2014-2019)
8.2 Chronic Obstructive Pulmonary Disease Key Players in Japan
8.3 Japan Chronic Obstructive Pulmonary Disease Market Size by Type
8.4 Japan Chronic Obstructive Pulmonary Disease Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Chronic Obstructive Pulmonary Disease Market Size (2014-2019)
9.2 Chronic Obstructive Pulmonary Disease Key Players in Southeast Asia
9.3 Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Type
9.4 Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Application
10 India
10.1 India Chronic Obstructive Pulmonary Disease Market Size (2014-2019)
10.2 Chronic Obstructive Pulmonary Disease Key Players in India
10.3 India Chronic Obstructive Pulmonary Disease Market Size by Type
10.4 India Chronic Obstructive Pulmonary Disease Market Size by Application
11 Central & South America
11.1 Central & South America Chronic Obstructive Pulmonary Disease Market Size (2014-2019)
11.2 Chronic Obstructive Pulmonary Disease Key Players in Central & South America
11.3 Central & South America Chronic Obstructive Pulmonary Disease Market Size by Type
11.4 Central & South America Chronic Obstructive Pulmonary Disease Market Size by Application
12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Chronic Obstructive Pulmonary Disease Introduction
12.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.1.5 AstraZeneca Recent Development
12.2 GSK
12.2.1 GSK Company Details
12.2.2 Company Description and Business Overview
12.2.3 Chronic Obstructive Pulmonary Disease Introduction
12.2.4 GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.2.5 GSK Recent Development
12.3 MSD
12.3.1 MSD Company Details
12.3.2 Company Description and Business Overview
12.3.3 Chronic Obstructive Pulmonary Disease Introduction
12.3.4 MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.3.5 MSD Recent Development
12.4 Sunovion
12.4.1 Sunovion Company Details
12.4.2 Company Description and Business Overview
12.4.3 Chronic Obstructive Pulmonary Disease Introduction
12.4.4 Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.4.5 Sunovion Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Chronic Obstructive Pulmonary Disease Introduction
12.5.4 Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Roche Group
12.6.1 Roche Group Company Details
12.6.2 Company Description and Business Overview
12.6.3 Chronic Obstructive Pulmonary Disease Introduction
12.6.4 Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.6.5 Roche Group Recent Development
12.7 Pfizer
12.7.1 Pfizer Company Details
12.7.2 Company Description and Business Overview
12.7.3 Chronic Obstructive Pulmonary Disease Introduction
12.7.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.7.5 Pfizer Recent Development
12.8 Jubilant Pharma Limited
12.8.1 Jubilant Pharma Limited Company Details
12.8.2 Company Description and Business Overview
12.8.3 Chronic Obstructive Pulmonary Disease Introduction
12.8.4 Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.8.5 Jubilant Pharma Limited Recent Development
12.9 Almirall
12.9.1 Almirall Company Details
12.9.2 Company Description and Business Overview
12.9.3 Chronic Obstructive Pulmonary Disease Introduction
12.9.4 Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.9.5 Almirall Recent Development
12.10 Horizon Pharma
12.10.1 Horizon Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Chronic Obstructive Pulmonary Disease Introduction
12.10.4 Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)
12.10.5 Horizon Pharma Recent Development
12.11 Boehringer Ingelheim
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Chronic Obstructive Pulmonary Disease Key Market Segments
Table Key Players Chronic Obstructive Pulmonary Disease Covered
Table Global Chronic Obstructive Pulmonary Disease Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Type 2014-2025
Figure Bronchodilators Figures
Table Key Players of Bronchodilators
Figure Glucocorticoids Figures
Table Key Players of Glucocorticoids
Figure Other Figures
Table Key Players of Other
Table Global Chronic Obstructive Pulmonary Disease Market Size Growth by Application 2014-2025 (Million US$)
Figure Prevention Case Studies
Figure Diagnostic Case Studies
Figure Treatment Case Studies
Figure Chronic Obstructive Pulmonary Disease Report Years Considered
Table Global Chronic Obstructive Pulmonary Disease Market Size 2014-2025 (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Regions 2014-2025 (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Regions 2014-2019 (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Share by Regions 2014-2019
Figure Global Chronic Obstructive Pulmonary Disease Market Share by Regions 2014-2019
Figure Global Chronic Obstructive Pulmonary Disease Market Share by Regions 2019
Table Market Top Trends
Table Global Chronic Obstructive Pulmonary Disease Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Share by Manufacturers (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease Market Share by Manufacturers in 2018
Table Global Chronic Obstructive Pulmonary Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Chronic Obstructive Pulmonary Disease Product/Solution/Service
Table Date of Enter into Chronic Obstructive Pulmonary Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019) (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size Share by Type (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Type (2014-2019)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table Global Chronic Obstructive Pulmonary Disease Market Size Share by Application (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Market Share by Application (2014-2019)
Figure Global Chronic Obstructive Pulmonary Disease Revenue Market Share by Application in 2018
Figure United States Chronic Obstructive Pulmonary Disease Market Size 2014-2019 (Million US$)
Table United States Key Players Chronic Obstructive Pulmonary Disease Revenue (2018-2019) (Million US$)
Table United States Key Players Chronic Obstructive Pulmonary Disease Market Share (2018-2019)
Table United States Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019) (Million US$)
Table United States Chronic Obstructive Pulmonary Disease Market Share by Type (2014-2019)
Table United States Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table United States Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2019)
Figure Europe Chronic Obstructive Pulmonary Disease Market Size 2014-2019 (Million US$)
Table Europe Key Players Chronic Obstructive Pulmonary Disease Revenue (2018-2019) (Million US$)
Table Europe Key Players Chronic Obstructive Pulmonary Disease Market Share (2018-2019)
Table Europe Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019) (Million US$)
Table Europe Chronic Obstructive Pulmonary Disease Market Share by Type (2014-2019)
Table Europe Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table Europe Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2019)
Figure China Chronic Obstructive Pulmonary Disease Market Size 2014-2019 (Million US$)
Table China Key Players Chronic Obstructive Pulmonary Disease Revenue (2018-2019) (Million US$)
Table China Key Players Chronic Obstructive Pulmonary Disease Market Share (2018-2019)
Table China Chronic Obstructive Pulmonary Disease Market Size by Type (2014-20189) (Million US$)
Table China Chronic Obstructive Pulmonary Disease Market Share by Type (2014-2019)
Table China Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table China Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2019)
Figure Japan Chronic Obstructive Pulmonary Disease Market Size 2014-2019 (Million US$)
Table Japan Key Players Chronic Obstructive Pulmonary Disease Revenue (2018-2019) (Million US$)
Table Japan Key Players Chronic Obstructive Pulmonary Disease Market Share (2018-2019)
Table Japan Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019) (Million US$)
Table Japan Chronic Obstructive Pulmonary Disease Market Share by Type (2014-2019)
Table Japan Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table Japan Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2019)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disease Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Chronic Obstructive Pulmonary Disease Market Share (2018-2019)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Share by Type (2014-2019)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2019)
Figure India Chronic Obstructive Pulmonary Disease Market Size 2014-2019 (Million US$)
Table India Key Players Chronic Obstructive Pulmonary Disease Revenue (2018-2019) (Million US$)
Table India Key Players Chronic Obstructive Pulmonary Disease Market Share (2018-2019)
Table India Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019) (Million US$)
Table India Chronic Obstructive Pulmonary Disease Market Share by Type (2014-2019)
Table India Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table India Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2019)
Figure Central & South America Chronic Obstructive Pulmonary Disease Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Chronic Obstructive Pulmonary Disease Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Chronic Obstructive Pulmonary Disease Market Share (2018-2019)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Size by Type (2014-2019) (Million US$)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Share by Type (2014-2019)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Size by Application (2014-2019) (Million US$)
Table Central & South America Chronic Obstructive Pulmonary Disease Market Share by Application (2014-2019)
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019) (Million US$)
Figure AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table AstraZeneca Recent Development
Table GSK Company Details
Table GSK Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table GSK Recent Development
Table MSD Company Details
Table MSD Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure MSD Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table MSD Recent Development
Table Sunovion Company Details
Table Sunovion Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure Sunovion Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table Sunovion Recent Development
Table Novartis Company Details
Table Novartis Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table Novartis Recent Development
Table Roche Group Company Details
Table Roche Group Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure Roche Group Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table Roche Group Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table Pfizer Recent Development
Table Jubilant Pharma Limited Company Details
Table Jubilant Pharma Limited Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure Jubilant Pharma Limited Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table Jubilant Pharma Limited Recent Development
Table Almirall Company Details
Table Almirall Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table Almirall Recent Development
Table Horizon Pharma Company Details
Table Horizon Pharma Revenue in Chronic Obstructive Pulmonary Disease Business (2014-2019)(Million US$)
Figure Horizon Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disease Business (2014-2019)
Table Horizon Pharma Recent Development
Table Boehringer Ingelheim Company Details
Table Global Chronic Obstructive Pulmonary Disease Market Size by Regions (Million US$) 2019-2025
Figure Global Chronic Obstructive Pulmonary Disease Market Size Share by Regions (2019-2025)
Figure Global Chronic Obstructive Pulmonary Disease Market Size Share by Regions in 2025
Figure United States Chronic Obstructive Pulmonary Disease Market Size Forecast (2019-2025)(Million USD)
Figure Europe Chronic Obstructive Pulmonary Disease Market Size Forecast (2019-2025)(Million USD)
Figure China Chronic Obstructive Pulmonary Disease Market Size Forecast (2019-2025)(Million USD)
Figure Japan Chronic Obstructive Pulmonary Disease Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Chronic Obstructive Pulmonary Disease Market Size Forecast (2019-2025)(Million USD)
Figure India Chronic Obstructive Pulmonary Disease Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Chronic Obstructive Pulmonary Disease Market Size Forecast (2019-2025)(Million USD)
Table Global Chronic Obstructive Pulmonary Disease Market Size by Product (2019-2025) (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Product (2019-2025)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Product in 2025
Table Global Chronic Obstructive Pulmonary Disease Market Size by Application (2019-2025) (Million US$)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Application (2019-2025)
Figure Global Chronic Obstructive Pulmonary Disease Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
慢性閉塞性肺疾患の世界市場：市場規模・現状・予測 Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.The…- 慢性肺疾患治療の世界市場：市場規模・現状・予測 Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…
- 慢性骨髄性白血病治療の世界市場：市場規模・現状・予測 Chronic myeloid leukemia (CML) is also known as chronic myelogenous leukemia. It's a type of cancer that starts in certain blood-forming cells of the bone marrow.In 2018, the global Chronic Myelogenous Leukemia Treatment market size was xx million US$ and it is expected to reach xx million US$ by th…
- 世界の慢性腎臓病-ミネラル・骨障害（CKD-MBD）市場：専門的調査 Chronic kidney disease mineral bone disorder (MBD) belongs to the bone disease pathology, is characterized by "inadequate bone mineralization" (bonemineralizationdeficiency), which is associated with chronic kidney disease of electrolyte and the direct result of endocrine disorder. The global Chroni…
- 痛風病治療の世界市場：市場規模・現状・予測 Gout is a disease characterized by recurrent attacks of acute inflammatory arthritis.The increase in the number of gout disease incidences and strong development of the treatment are some of the major factors driving the global gout disease treatment market. Improvised study on gout therapeutics and…